2006 in pharma — approvals, patent cliffs, Phase 3 readouts
FDA / EMA / MHRA approvals (34)
- — Tykerb · Novartis · Oncology
- — Neupro · UCB · Neuroscience
- — Tasigna · Cipla · Oncology
- — Torisel · Pfizer · Oncology
- — Vyvanse · Takeda · Metabolic
- — Selzentry · GSK · Immunology
- — INFLUENZA B VIRUS, INACTIVATED NEURAMINIDASE
- — INSULIN, NEUTRAL
- — AMMONIA SOLUTION, STRONG
- — NILOTINIB HYDROCHLORIDE MONOHYDRATE
- — SEVELAMER
- — Doribax · Shionogi · Infectious Disease
- — Jalra · Metabolic
- — Melatol · Rad Neurim Pharmaceuticals Eec Sarl · Other
- — Fludarabine Phosphate · Genzyme Corp · Oncology
- — AMMONIA N 13 · Other
- — STIRIPENTOL
- — Altabax · Almirall · Infectious Disease
- — Letairis · Gilead Sciences · Cardiovascular
- — Cefpodoxime Proxetil · Pfizer · Metabolic
- — GARENOXACIN MESYLATE
- — Renvela · Sanofi · Hematology
- — Xyzal · Sanofi · Immunology
- — Mircera · Hoffman-La Roche · Metabolic
- — Ixempra Kit · R-Pharm Us Llc · Oncology
- — Somatuline Depot · Ipsen Pharma · Other
- — Torisel · Pfizer · Oncology
- — Silapo · Hospira UK Limited · Hematology
- — Tekturna · Lxo Ireland · Cardiovascular
- — Nuvigil · Nuvo Pharms · Rare Disease
- — Kuvan · BioMarin · Oncology
- — H5G1.1 · AstraZeneca · Neuroscience
- — Arnuity Ellipta · Haleon Us Holdings · Respiratory
- — Geninax · Infectious Disease